Hopefully her second MAFS groom Clint lives up to those expectations. With Lauren back and linked to season 11's Jono McCullough, everyone wants to know more about about her. So, here's everything ...

US-based pharmaceutical giant Eli Lilly has launched its diabetes and weight ... Just like Novo Nordisk's Ozempic, it also helps with effective weight loss. Tirzepatide works by mimicking two ...

Eli Lilly Weight Loss Drug: India's obesity crisis is intensifying, with big pharma companies like Eli Lilly and Novo Nordisk competing to introduce weight-loss drugs in the market. The economic ...

Eli Lilly’s Mounjaro is a once-weekly injection approved by India’s drug regulator, is priced at 4,375 rupees ($50.67) for a 5 mg vial and 3,500 rupees ($40.54) for a 2.5 mg vial, its lowest ...

The 2.5 mg vial is priced at Rs 3,500 (MRP) and the 5 mg vial is priced at Rs 4,375(MRP). This India-specific pricing is part of El Lilly’s effort to expand access. The drug — along with Novo ...

86000 to 1 lakh. The company spokesperson said, "This India-specific pricing reflects Lilly’s commitment to expanding access to innovative treatments in the country." Mounjaro, also known as ...

Meanwhile, India’s largest pharma company, Sun Pharmaceutical Industries is working on its own GLP-1 drug. “Semaglutide generics will be priced almost 95% lower than [Eli Lilly'] current price ...

Singaporean artist Lakshmi Mohanbabu (R) looks at her one of her art pieces, placed in a holder designed by NuStar Technologies that can bring it to the ocean floor, displayed at the ART NOW gallery.

Dr Reddy’s Laboratories is also working on a generic version of Wegovy. (Image/Getty) US pharma major Eli Lilly on Thursday launched its global bestseller anti-obesity and diabetes drug Mounjaro ...

Lilly launched the drug in a single dose vial following the marketing authorisation from the Central Drugs Standard Control Organization (CDSCO). It has been priced at Rs 3,500 for a 2.5 mg vial and ...

The average monthly price of Mounjaro in the U.S. is about $1,000 to $1,200 (approximately ₹86,000 to ₹1 lakh). “This India-specific pricing reflects Lilly’s commitment to expanding access ...

With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight ...